Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Corpay, Inc. stock logo
CPAY
Corpay
$327.22
+0.4%
$328.04
$247.10
$400.81
$22.99B0.98488,466 shs567,228 shs
CGI Inc. stock logo
GIB
CGI
$106.28
+0.3%
$102.52
$92.85
$122.79
$24.10B0.78200,554 shs225,894 shs
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$153.39
+0.1%
$165.23
$135.97
$252.88
$27.04B1.341.46 million shs2.67 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$300.81
+0.3%
$307.83
$250.05
$459.77
$8.65B1.55346,627 shs340,317 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Corpay, Inc. stock logo
CPAY
Corpay
-0.45%-0.07%+12.96%-16.41%+6.80%
CGI Inc. stock logo
GIB
CGI
+1.16%+0.00%+9.06%-11.01%+2.85%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
+4.85%-1.22%+0.32%-26.96%-33.17%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+3.62%-2.82%+3.31%-16.97%-25.47%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Corpay, Inc. stock logo
CPAY
Corpay
4.2432 of 5 stars
3.45.00.00.03.92.52.5
CGI Inc. stock logo
GIB
CGI
3.8995 of 5 stars
3.63.01.70.02.71.72.5
IQVIA Holdings Inc. stock logo
IQV
IQVIA
4.9684 of 5 stars
4.45.00.04.63.91.72.5
Medpace Holdings, Inc. stock logo
MEDP
Medpace
4.6427 of 5 stars
3.11.00.04.63.65.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Corpay, Inc. stock logo
CPAY
Corpay
2.75
Moderate Buy$395.0720.73% Upside
CGI Inc. stock logo
GIB
CGI
3.20
Buy$156.7547.48% Upside
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.75
Moderate Buy$231.7151.07% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.23
Hold$349.3016.12% Upside

Current Analyst Ratings Breakdown

Latest MEDP, IQV, GIB, and CPAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2025
Corpay, Inc. stock logo
CPAY
Corpay
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$417.00 ➝ $414.00
5/7/2025
Corpay, Inc. stock logo
CPAY
Corpay
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$400.00 ➝ $365.00
5/7/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$195.00 ➝ $161.00
5/7/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$255.00 ➝ $185.00
5/7/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$170.00 ➝ $165.00
4/28/2025
Corpay, Inc. stock logo
CPAY
Corpay
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
4/25/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/25/2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$260.00 ➝ $160.00
4/24/2025
Corpay, Inc. stock logo
CPAY
Corpay
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$375.00 ➝ $339.00
4/23/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$333.00 ➝ $300.00
4/23/2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$340.00 ➝ $313.00
(Data available from 5/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Corpay, Inc. stock logo
CPAY
Corpay
$3.97B5.78$21.89 per share14.95$45.13 per share7.25
CGI Inc. stock logo
GIB
CGI
$15.14B1.59$6.73 per share15.80$31.05 per share3.42
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$15.41B1.76$13.13 per share11.68$34.45 per share4.45
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.16B4.01$12.17 per share24.72$27.10 per share11.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Corpay, Inc. stock logo
CPAY
Corpay
$1.00B$13.9823.4114.131.3225.25%41.46%7.55%N/A
CGI Inc. stock logo
GIB
CGI
$1.24B$5.4919.2216.922.5811.72%19.32%10.82%N/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$1.37B$7.5020.4512.571.998.91%28.81%7.02%7/21/2025 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$404.39M$13.1023.8222.023.8119.17%51.48%20.47%N/A

Latest MEDP, IQV, GIB, and CPAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Corpay, Inc. stock logo
CPAY
Corpay
$4.50$4.51+$0.01$3.40$1.02 billion$1.01 billion
5/6/2025Q1 2025
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$2.63$2.70+$0.07$1.40$3.77 billion$3.83 billion
4/30/2025Q2 2025
CGI Inc. stock logo
GIB
CGI
$1.50$1.48-$0.02$1.32$4.05 billion$2.80 billion
4/21/2025Q1 2025
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.06$3.67+$0.61$3.67$528.38 million$558.57 million
2/10/2025Q4 2024
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.96$3.67+$0.71$3.67$534.99 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Corpay, Inc. stock logo
CPAY
Corpay
N/AN/AN/AN/AN/A
CGI Inc. stock logo
GIB
CGI
$0.410.39%N/A7.47%N/A
IQVIA Holdings Inc. stock logo
IQV
IQVIA
N/AN/AN/AN/AN/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A

Latest MEDP, IQV, GIB, and CPAY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
CGI Inc. stock logo
GIB
CGI
quarterly$0.10860.4%5/16/20255/16/20256/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Corpay, Inc. stock logo
CPAY
Corpay
1.66
1.00
1.05
CGI Inc. stock logo
GIB
CGI
0.28
1.31
1.04
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2.12
0.84
0.84
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.93
0.93

Institutional Ownership

CompanyInstitutional Ownership
Corpay, Inc. stock logo
CPAY
Corpay
98.84%
CGI Inc. stock logo
GIB
CGI
66.68%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
89.62%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%

Insider Ownership

CompanyInsider Ownership
Corpay, Inc. stock logo
CPAY
Corpay
6.10%
CGI Inc. stock logo
GIB
CGI
9.90%
IQVIA Holdings Inc. stock logo
IQV
IQVIA
1.60%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Corpay, Inc. stock logo
CPAY
Corpay
10,50070.25 million65.46 millionOptionable
CGI Inc. stock logo
GIB
CGI
90,000226.73 million204.29 millionOptionable
IQVIA Holdings Inc. stock logo
IQV
IQVIA
86,000176.32 million173.28 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
5,20028.74 million24.28 millionOptionable

Recent News About These Companies

Greater Cincinnati cocktail bar to shutter

New MarketBeat Followers Over Time

Media Sentiment Over Time

Corpay stock logo

Corpay NYSE:CPAY

$327.22 +1.37 (+0.42%)
Closing price 03:59 PM Eastern
Extended Trading
$326.98 -0.24 (-0.07%)
As of 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Corpay, Inc. operates as a payments company that helps businesses and consumers manage vehicle-related expenses, lodging expenses, and corporate payments in the United States, Brazil, the United Kingdom, and internationally. The company offers vehicle payment solutions, which include fuel, tolls, parking, fleet maintenance, and long-haul transportation services, as well as prepaid food and transportation vouchers and cards. It also provides corporate payment solutions consisting of accounts payable automation; virtual cards, cross-border solutions; and purchasing and travel and entertainment card products, as well as lodging payments solutions for employees who travel overnight for work purposes; traveling crews and stranded passengers from airlines and cruise lines; and insurance policyholders displaced from their homes due to damage or catastrophe. In addition, the company offers gifts and payroll cards. It serves business, merchant, consumer, and payment network customers. The company was formerly known as FLEETCOR Technologies, Inc. and changed its name to Corpay, Inc. in March 2024. Corpay, Inc. was founded in 1986 and is headquartered in Atlanta, Georgia.

CGI stock logo

CGI NYSE:GIB

$106.28 +0.28 (+0.27%)
Closing price 03:59 PM Eastern
Extended Trading
$106.23 -0.05 (-0.05%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CGI Inc., together with its subsidiaries, provides information technology (IT) and business process services. Its services include the business and strategic IT consulting, systems integration, and software solutions. The company also provides application development, modernization and maintenance, holistic enterprise digitization, automation, hybrid and cloud management, and business process services; intellectual property-based solutions; business consulting; managed IT services; and IT infrastructure services. It serves clients operating in government, banking and capital market, health, utility, communication and media, oil and gas, space, manufacturing, insurance, life sciences, retail and consumer service, and transportation and logistics sectors. The company operates in Canada, France, Spain, Portugal, the United States, Germany, Sweden, Norway, the United Kingdom, Australia, Finland, Poland, Baltics, the Netherlands, Denmark, Czech Republic, India, the Philippines, Asia Pacific, and internationally. Western and Southern Europe; Australia; Scandinavia; Finland, Poland, and Baltics; the United States; the United Kingdom; and the Asia Pacific. The company was formerly known as CGI Group Inc. and changed its name to CGI Inc. in January 2019. CGI Inc. was founded in 1976 and is headquartered in Montreal, Canada.

IQVIA stock logo

IQVIA NYSE:IQV

$153.38 +0.09 (+0.06%)
Closing price 03:59 PM Eastern
Extended Trading
$153.29 -0.09 (-0.06%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Medpace stock logo

Medpace NASDAQ:MEDP

$300.81 +0.82 (+0.27%)
Closing price 04:00 PM Eastern
Extended Trading
$300.81 0.00 (0.00%)
As of 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.